An observational study in Keratitis and Myopia, sponsored by Ohio State University. Completed. Open to participants aged 5 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-29.
Sponsored by Ohio State University · Observational
This retrospective chart review study compares the incidence of corneal inflammation due to infection in children vs. adult patients wearing overnight corneal reshaping lenses.
129 studies on the registry are indexed under Keratitis; 14 are open to participants now.
This study's enrollment of 1,317 is above the median of 100 across 38 observational studies indexed under Keratitis.
Browse Keratitis studies →Ohio State University is the lead sponsor of 658 studies on the registry; 145 are open to participants now.
Of its 66 completed or terminated interventional studies of FDA-regulated products, 49 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Randomized sample of optometry and ophthalmology patients seen by 200 practitioners in various practice settings, stratified on manufacturer, practitioner volume.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Microbial keratitis incidence
Incidence of microbial keratitis in children vs. adults with the use of two brands of corneal reshaping lenses.
Time frame: 1 year
No study locations are listed for this record.
The record gives a start of Feb 2008, a primary completion of Oct 2010 and a completion of Oct 2010. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.